Eads & Heald Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,749
Closed -$308K 139
2025
Q1
$308K Sell
2,749
-732
-21% -$82K 0.16% 122
2024
Q4
$322K Sell
3,481
-67
-2% -$6.2K 0.16% 121
2024
Q3
$297K Hold
3,548
0.14% 125
2024
Q2
$243K Sell
3,548
-299
-8% -$20.5K 0.12% 132
2024
Q1
$282K Buy
3,847
+311
+9% +$22.8K 0.13% 126
2023
Q4
$286K Sell
3,536
-48
-1% -$3.88K 0.14% 125
2023
Q3
$269K Sell
3,584
-15
-0.4% -$1.13K 0.14% 125
2023
Q2
$277K Sell
3,599
-106
-3% -$8.16K 0.14% 128
2023
Q1
$307K Buy
3,705
+375
+11% +$31.1K 0.15% 124
2022
Q4
$286K Sell
3,330
-1,050
-24% -$90.2K 0.15% 129
2022
Q3
$270K Buy
4,380
+530
+14% +$32.7K 0.15% 128
2022
Q2
$238K Buy
+3,850
New +$238K 0.13% 141
2022
Q1
Sell
-4,418
Closed -$321K 149
2021
Q4
$321K Buy
4,418
+31
+0.7% +$2.25K 0.14% 129
2021
Q3
$306K Buy
4,387
+1,051
+32% +$73.3K 0.15% 126
2021
Q2
$230K Buy
3,336
+223
+7% +$15.4K 0.11% 130
2021
Q1
$201K Buy
+3,113
New +$201K 0.1% 136
2020
Q4
Sell
-3,228
Closed -$204K 133
2020
Q3
$204K Buy
+3,228
New +$204K 0.12% 124
2016
Q4
Sell
-4,460
Closed -$353K 134
2016
Q3
$353K Sell
4,460
-2,899
-39% -$229K 0.24% 112
2016
Q2
$614K Sell
7,359
-138
-2% -$11.5K 0.42% 93
2016
Q1
$689K Sell
7,497
-110
-1% -$10.1K 0.48% 87
2015
Q4
$770K Sell
7,607
-550
-7% -$55.7K 0.53% 81
2015
Q3
$801K Buy
8,157
+419
+5% +$41.1K 0.57% 78
2015
Q2
$906K Buy
7,738
+4,034
+109% +$472K 0.6% 77
2015
Q1
$363K Buy
3,704
+880
+31% +$86.2K 0.23% 114
2014
Q4
$266K Buy
+2,824
New +$266K 0.17% 115